Applying justice in clinical trials for diverse populations

Jon C Tilburt, Jean G. Ford, Mollie W. Howerton, Tiffany L. Gary, Gabriel Y. Lai, Shari Bolen, Charles Baffi, Renee F. Wilson, Teerath Peter Tanpitukpongse, Neil R. Powe, Eric B. Bass, Jeremy Sugarman

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Considerable attention has focused on increasing clinical trial participation for members of "underrepresented groups". However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation. Purpose: To examine the ethical principle of justice as it applies to recruiting diverse populations to clinical trials representation. Methods: In this paper, we analyse the conceptual and practical challenges in applying the principle of justice to clinical trials representation. Results: Different facets of justice include demands for both fair outcomes and fair processes. Including both of these facets in clinical trials policy should not only promote access to trials, but also help to provide a framework to improve fairness in representation in clinical trials. Efforts to evaluate recruitment of representation should include outcome and process measures. Limitations: The suggestions offered based on this conceptual analysis need to be tested empirically. Conclusions: Those involved in the design, conduct and oversight of clinical trials should consider all of the facets of justice when assessing representation in clinical trials and attempt to balance fair access to trials with a fair process that may require protection from being unduly pressured to participate.

Original languageEnglish (US)
Pages (from-to)264-269
Number of pages6
JournalClinical Trials
Volume4
Issue number3
DOIs
StatePublished - 2007
Externally publishedYes

Fingerprint

Social Justice
Clinical Trials
Population
Process Assessment (Health Care)
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Tilburt, J. C., Ford, J. G., Howerton, M. W., Gary, T. L., Lai, G. Y., Bolen, S., ... Sugarman, J. (2007). Applying justice in clinical trials for diverse populations. Clinical Trials, 4(3), 264-269. https://doi.org/10.1177/1740774507079440

Applying justice in clinical trials for diverse populations. / Tilburt, Jon C; Ford, Jean G.; Howerton, Mollie W.; Gary, Tiffany L.; Lai, Gabriel Y.; Bolen, Shari; Baffi, Charles; Wilson, Renee F.; Tanpitukpongse, Teerath Peter; Powe, Neil R.; Bass, Eric B.; Sugarman, Jeremy.

In: Clinical Trials, Vol. 4, No. 3, 2007, p. 264-269.

Research output: Contribution to journalArticle

Tilburt, JC, Ford, JG, Howerton, MW, Gary, TL, Lai, GY, Bolen, S, Baffi, C, Wilson, RF, Tanpitukpongse, TP, Powe, NR, Bass, EB & Sugarman, J 2007, 'Applying justice in clinical trials for diverse populations', Clinical Trials, vol. 4, no. 3, pp. 264-269. https://doi.org/10.1177/1740774507079440
Tilburt, Jon C ; Ford, Jean G. ; Howerton, Mollie W. ; Gary, Tiffany L. ; Lai, Gabriel Y. ; Bolen, Shari ; Baffi, Charles ; Wilson, Renee F. ; Tanpitukpongse, Teerath Peter ; Powe, Neil R. ; Bass, Eric B. ; Sugarman, Jeremy. / Applying justice in clinical trials for diverse populations. In: Clinical Trials. 2007 ; Vol. 4, No. 3. pp. 264-269.
@article{25f4677192344963905273a0fca073b0,
title = "Applying justice in clinical trials for diverse populations",
abstract = "Background: Considerable attention has focused on increasing clinical trial participation for members of {"}underrepresented groups{"}. However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation. Purpose: To examine the ethical principle of justice as it applies to recruiting diverse populations to clinical trials representation. Methods: In this paper, we analyse the conceptual and practical challenges in applying the principle of justice to clinical trials representation. Results: Different facets of justice include demands for both fair outcomes and fair processes. Including both of these facets in clinical trials policy should not only promote access to trials, but also help to provide a framework to improve fairness in representation in clinical trials. Efforts to evaluate recruitment of representation should include outcome and process measures. Limitations: The suggestions offered based on this conceptual analysis need to be tested empirically. Conclusions: Those involved in the design, conduct and oversight of clinical trials should consider all of the facets of justice when assessing representation in clinical trials and attempt to balance fair access to trials with a fair process that may require protection from being unduly pressured to participate.",
author = "Tilburt, {Jon C} and Ford, {Jean G.} and Howerton, {Mollie W.} and Gary, {Tiffany L.} and Lai, {Gabriel Y.} and Shari Bolen and Charles Baffi and Wilson, {Renee F.} and Tanpitukpongse, {Teerath Peter} and Powe, {Neil R.} and Bass, {Eric B.} and Jeremy Sugarman",
year = "2007",
doi = "10.1177/1740774507079440",
language = "English (US)",
volume = "4",
pages = "264--269",
journal = "Clinical Trials",
issn = "1740-7745",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Applying justice in clinical trials for diverse populations

AU - Tilburt, Jon C

AU - Ford, Jean G.

AU - Howerton, Mollie W.

AU - Gary, Tiffany L.

AU - Lai, Gabriel Y.

AU - Bolen, Shari

AU - Baffi, Charles

AU - Wilson, Renee F.

AU - Tanpitukpongse, Teerath Peter

AU - Powe, Neil R.

AU - Bass, Eric B.

AU - Sugarman, Jeremy

PY - 2007

Y1 - 2007

N2 - Background: Considerable attention has focused on increasing clinical trial participation for members of "underrepresented groups". However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation. Purpose: To examine the ethical principle of justice as it applies to recruiting diverse populations to clinical trials representation. Methods: In this paper, we analyse the conceptual and practical challenges in applying the principle of justice to clinical trials representation. Results: Different facets of justice include demands for both fair outcomes and fair processes. Including both of these facets in clinical trials policy should not only promote access to trials, but also help to provide a framework to improve fairness in representation in clinical trials. Efforts to evaluate recruitment of representation should include outcome and process measures. Limitations: The suggestions offered based on this conceptual analysis need to be tested empirically. Conclusions: Those involved in the design, conduct and oversight of clinical trials should consider all of the facets of justice when assessing representation in clinical trials and attempt to balance fair access to trials with a fair process that may require protection from being unduly pressured to participate.

AB - Background: Considerable attention has focused on increasing clinical trial participation for members of "underrepresented groups". However, doing so involves clarifying how to meet the demands of justice, or fairness, which provides the ethical mandate to enhance broad trial representation. Purpose: To examine the ethical principle of justice as it applies to recruiting diverse populations to clinical trials representation. Methods: In this paper, we analyse the conceptual and practical challenges in applying the principle of justice to clinical trials representation. Results: Different facets of justice include demands for both fair outcomes and fair processes. Including both of these facets in clinical trials policy should not only promote access to trials, but also help to provide a framework to improve fairness in representation in clinical trials. Efforts to evaluate recruitment of representation should include outcome and process measures. Limitations: The suggestions offered based on this conceptual analysis need to be tested empirically. Conclusions: Those involved in the design, conduct and oversight of clinical trials should consider all of the facets of justice when assessing representation in clinical trials and attempt to balance fair access to trials with a fair process that may require protection from being unduly pressured to participate.

UR - http://www.scopus.com/inward/record.url?scp=34548622094&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548622094&partnerID=8YFLogxK

U2 - 10.1177/1740774507079440

DO - 10.1177/1740774507079440

M3 - Article

VL - 4

SP - 264

EP - 269

JO - Clinical Trials

JF - Clinical Trials

SN - 1740-7745

IS - 3

ER -